HEAL initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression Without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development) (UG3/UH3 Clinical Trials Not Allowed)

Funding Opportunity RFA-HL-22-013 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) aims to stimulate the pre-clinical development of novel, pharmacotherapeutic candidates to selectively counteract opioid induced respiratory depression (OIRD), without blocking opioid analgesic benefits or inducing acute opioid withdrawal.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding